Occudo Quantitative Strategies’s Advent Technologies ADN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,558
Closed -$108K 1107
2022
Q1
$108K Buy
1,558
+547
+54% +$61.9K 0.01% 1014
2021
Q4
$213K Buy
+1,011
New +$252K 0.02% 874
2021
Q3
Sell
-1,753
Closed -$507K 990
2021
Q2
$507K Buy
+1,753
New +$583K 0.08% 425

Other funds holding ADN

Occudo Quantitative Strategies's ADN Position: Q2 2022 in Review

Occudo Quantitative Strategies sold out of Advent Technologies (ADN) in Q2 2022, closing a stake of 1,558 shares — an estimated $108K sold.

Occudo Quantitative Strategies first reported a position in ADN in Q2 2021 and held it in 3 quarters. The position peaked at $507K in Q2 2021. 49 funds tracked by Wall St. Rank hold ADN as of Q2 2022.

  • Occudo Quantitative Strategies reported no remaining Advent Technologies position as of Q2 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 1,558 Advent Technologies shares in Q2 2022, an estimated $108K.
  • Occudo Quantitative Strategies first reported a position in Advent Technologies in Q2 2021 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Advent Technologies position peaked at $507K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held Advent Technologies as of Q2 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.